Early research (Phase 1)Study completedNCT00004047What this trial is testingChemotherapy in Treating Patients Who Have Hematologic CancerWho this might be right forLeukemiaMyelodysplastic Syndromes Daiichi Sankyo
Testing effectiveness (Phase 2)Study completedNCT00365287What this trial is testingCombination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney CancerWho this might be right forBreast CancerKidney CancerLeukemia+3 more Masonic Cancer Center, University of Minnesota 148
Early research (Phase 1)Study completedNCT02214147What this trial is testingPharmacokinetics of Alisertib in Adults With Advanced Solid Tumors or Relapsed/Refractory Lymphoma With Varying Degrees of Hepatic FunctionWho this might be right forAdvanced Solid TumorsRelapsed/Refractory Lymphoma Millennium Pharmaceuticals, Inc. 36
Early research (Phase 1)Study completedNCT02259010What this trial is testingEvaluate the Effect of Itraconazole on the Pharmacokinetics of Alisertib in Participants With Advanced Solid Tumors or Relapsed/Refractory LymphomaWho this might be right forAdvanced Solid TumorsRelapsed/Refractory Lymphoma Millennium Pharmaceuticals, Inc. 24
Early research (Phase 1)Study completedNCT00002980What this trial is testingDecitabine in Treating Patients With Melanoma or Other Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more California Cancer Consortium
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544115What this trial is testingDonor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other DisordersWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more City of Hope Medical Center 260
Testing effectiveness (Phase 2)UnknownNCT01799083What this trial is testingLower Dose Decitabine Based Therapy in Patients With Refractory and/or Chemotherapy Resistant Solid Tumors or B Cell LymphomasWho this might be right forSolid TumorsB Cell Lymphoma Han weidong 100
Testing effectiveness (Phase 2)Ended earlyNCT04775680What this trial is testingStudy of ADG106 In Combination With PD-1 Antibody In Advanced or Metastatic Solid Tumors and/or Non Hodgkin LymphomaWho this might be right forSolid TumorNon Hodgkin Lymphoma Adagene (Suzhou) Limited 25
Testing effectiveness (Phase 2)Looking for participantsNCT04390737What this trial is testingEvaluate the Safety and Clinical Activity of HH2853Who this might be right forFL LymphomaEpithelioid SarcomaPeripheral T Cell Lymphoma+1 more Haihe Biopharma Co., Ltd. 254
Early research (Phase 1)Study completedNCT00709033What this trial is testingT-cells or EBV Specific CTLs, Advanced B-Cell NHL and CLLWho this might be right forNon-Hodgkin LymphomaChronic Lymphocytic Leukemia Baylor College of Medicine 3
Early research (Phase 1)Active Not RecruitingNCT02520791What this trial is testingAnti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell LymphomaWho this might be right forAdvanced Primary Cutaneous T-Cell Non-Hodgkin LymphomaRecurrent Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-TypeRecurrent Grade 1 Follicular Lymphoma+16 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT03465891What this trial is testingStudy of the PD-L1 Inhibitor Atezolizumab With or Without Low-dose, Local Radiation in Patients With Relapsed or Refractory Advanced Stage Follicular LymphomaWho this might be right forLymphoma Memorial Sloan Kettering Cancer Center 2
Early research (Phase 1)Study completedNCT01129193What this trial is testingAR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+64 more Amir Mortazavi 44
Early research (Phase 1)Looking for participantsNCT06487624What this trial is testingAn Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced TumorsWho this might be right forAdvanced Solid TumorRefractory Hodgkin Lymphoma FBD Biologics Limited 50
Early research (Phase 1)Study completedNCT01471210What this trial is testingSafety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of Urelumab (BMS-663513) in Subjects With Advanced and/or Metastatic Solid Tumors and Relapsed/Refractory B-cell Non-Hodgkin's LymphomaWho this might be right forCancer - Solid Tumors and B-Cell Non-Hodgkin's Lymphoma Bristol-Myers Squibb 124
Testing effectiveness (Phase 2)Study completedNCT03213691What this trial is testingSelumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmAnn Arbor Stage III Childhood Non-Hodgkin LymphomaAnn Arbor Stage IV Childhood Non-Hodgkin Lymphoma+8 more National Cancer Institute (NCI) 21
Large-scale testing (Phase 3)Ended earlyNCT03138499What this trial is testingNivolumab Plus Brentuximab Vedotin Versus Brentuximab Vedotin Alone in Patients With Advanced Stage Classical Hodgkin Lymphoma, Who Are Relapsed/ Refractory or Who Are Not Eligible for Autologous Stem Cell Transplant,Who this might be right forHodgkin's Disease Bristol-Myers Squibb 23
Early research (Phase 1)Study completedNCT00243087What this trial is testingInvestigation of Safety, Tolerability and Maximum Tolerated Dose (MTD) of BI 2536 in Patients With Recurrent Advanced Aggressive Non-Hodgkin's Lymphoma (NHL)Who this might be right forLymphoma Boehringer Ingelheim 41
Early research (Phase 1)Study completedNCT00005593What this trial is testingFludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic SyndromeWho this might be right forLeukemiaMyelodysplastic Syndromes Case Comprehensive Cancer Center 31
Testing effectiveness (Phase 2)UnknownNCT04917250What this trial is testingGPED for Patients With Relapsed/Refractory or Advanced NK/T-cell LymphomaWho this might be right forExtranodal NK/T-cell Lymphoma Beijing Tongren Hospital 15